Best in Biotech 21 Jan 2025
14 biotech podcasts to tune into in 2025
Here is a list of 14 biotech podcasts to keep you up to date with the latest advances in the biotechnology industry.
Funding
- Latest Posts
In Depth 7 Jan 2025
The biggest private biotech investments in December 2024
The companies Nuvig Therapeutics, Ottimo Pharma, and Angitia Biopharmaceuticals bagged the biggest private biotech investments in December 2024.
Expert Advice 6 Jan 2025
What to look for in a biotech incubator
Building a biotech startup can be a daunting task and often founders rely on incubators – but how to choose the right one?
In Depth 5 Dec 2024
The biggest private biotech investments in November 2024
The companies Metsera, Alentis Therapeutics, and Adcendo bagged the biggest private biotech investments in November 2024.
Best in Biotech 28 Nov 2024
Six antisense oligonucleotide companies shaping the future of genetic medicine
Learn more about six antisense oligonucleotide companies shaping the future of genetic medicine, just as the market is expected to grow.
Expert Advice 15 Nov 2024
How biotech startups become unicorns
Delve into what differentiates a successful biotech startup from a unicorn reaching a $1 billion valuation.
ADVERTISEMENT
ADVERTISEMENT
Podcast 15 Nov 2024
Beyond profits: The Bill & Melinda Gates MRI’s mission to combat neglected diseases
This week, our guest is Dr Claire Wagner, head of corporate strategy and market access at the Bill & Melinda Gates Medical Research Institute (Gates MRI).
In Depth 7 Nov 2024
The biggest private biotech investments in October 2024
The companies Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics bagged the biggest private biotech investments in October 2024.
In Depth 5 Nov 2024
From consumer health to pure biopharma: Inside Sanofi’s strategic shift
Delve into Sanofi’s “play to win” strategy as investments are ramping up after their consumer health division’s divestment.
Best in Biotech 24 Oct 2024
Six biotech companies advancing multiple sclerosis therapies
Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease.
News and Trends 21 Oct 2024
Turning back time with cellular reprogramming: Shift raises $16 million in seed funding
As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related diseases.
News and Trends 15 Oct 2024
Booster launches to treat neurodegenerative diseases with proteasome activation
Discover Booster Therapeutics’ novel proteasome activation approach to neurodegenerative diseases as it launches with $15 million.
ADVERTISEMENT
